Skip to content

PREVent COVID - Assessing the Efficacy and Safety of the COVID 19 Vaccines in Children and Young Adults who have had a Solid Organ Transplant

Patients who have had an organ transplant take medications that weaken their body's immune system. Because of these medications, they tend to have weaker responses to vaccines. We are looking to see if patients who have had an organ transplant have a weaker response and are less protected by the new COVID-19 vaccines.

This a Canada-wide study that is looking to recruit healthy children and solid organ transplant patients who have just received or are going to receive their COVID-19 vaccine.

null

Conditions de participation

  • Sexe:

    Any

  • Âges admissibles:

    0 to 17

Critères de participation

Inclusion Criteria:
Healthy participants under the age of 18 who are not taking an medications that might decrease their immune system.

Solid organ transplant patients under the age of 18.

Children and teens should be planning to get their COVID-19 vaccine OR who have already received any doses of COVID-19 vaccine.
Exclusion Criteria:
None

Lieu de l'étude

University of Alberta
University of Alberta
Edmonton, Alberta
Canada

Contactez l'équipe d'étude

Primary Contact

Cheri Copithorne

[email protected]
780-248-5611
Étude parrainée par
University of Alberta
Participants recherchés
Plus d'informations
ID de l'étude: Pro00111263